111 related articles for article (PubMed ID: 29466187)
21. Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome.
Vafaie M; Slagman A; Möckel M; Hamm C; Huber K; Müller C; Vollert JO; Blankenberg S; Katus HA; Liebetrau C; Giannitsis E; Searle J
Am J Med; 2016 Mar; 129(3):274-82.e2. PubMed ID: 26524709
[TBL] [Abstract][Full Text] [Related]
22. [The significance of a 4,183 Da peptide of dermcidin protein in the early diagnosis and differential diagnosis of acute coronary syndrome].
Kai F; Lifeng L; Haijing S; Xianhua L; Hu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Dec; 27(12):970-4. PubMed ID: 27318339
[TBL] [Abstract][Full Text] [Related]
23. Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) study.
Karakas M; Januzzi JL; Meyer J; Lee H; Schlett CL; Truong QA; Rottbauer W; Bamberg F; Dasdemir S; Hoffmann U; Koenig W
Clin Chem; 2011 Aug; 57(8):1137-45. PubMed ID: 21673277
[TBL] [Abstract][Full Text] [Related]
24. Copeptin improves early diagnosis of acute myocardial infarction.
Keller T; Tzikas S; Zeller T; Czyz E; Lillpopp L; Ojeda FM; Roth A; Bickel C; Baldus S; Sinning CR; Wild PS; Lubos E; Peetz D; Kunde J; Hartmann O; Bergmann A; Post F; Lackner KJ; Genth-Zotz S; Nicaud V; Tiret L; Münzel TF; Blankenberg S
J Am Coll Cardiol; 2010 May; 55(19):2096-106. PubMed ID: 20447532
[TBL] [Abstract][Full Text] [Related]
25. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.
Kai H; Ikeda H; Yasukawa H; Kai M; Seki Y; Kuwahara F; Ueno T; Sugi K; Imaizumi T
J Am Coll Cardiol; 1998 Aug; 32(2):368-72. PubMed ID: 9708462
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of copeptin in acute myocardial infarction.
Ay MO; Erenler AK; Dogan T; Yetim M
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1576-1582. PubMed ID: 28429348
[TBL] [Abstract][Full Text] [Related]
27. Clinical Relevance of matrix metalloproteinase 9 in patients with acute coronary syndrome.
Hamed GM; Fattah MF
Clin Appl Thromb Hemost; 2015 Nov; 21(8):705-11. PubMed ID: 25616488
[TBL] [Abstract][Full Text] [Related]
28. Copeptin as a prognostic biomarker in acute myocardial infarction.
Lattuca B; Sy V; Nguyen LS; Bernard M; Zeitouni M; Overtchouk P; Yan Y; Hammoudi N; Ceccaldi A; Collet JP; Kerneis M; Diallo A; Montalescot G; Silvain J
Int J Cardiol; 2019 Jan; 274():337-341. PubMed ID: 30217427
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic role of copeptin in patients presenting with chest pain in the emergency room.
Folli C; Consonni D; Spessot M; Salvini L; Velati M; Ranzani G; Maiavacca R; Monzani V
Eur J Intern Med; 2013 Mar; 24(2):189-93. PubMed ID: 23063248
[TBL] [Abstract][Full Text] [Related]
30. [Usefulness of copeptin in the diagnosis of acute coronary syndrome in the emergency department of a tertiary hospital].
Calmarza P; Lapresta C; García-Castañón S; López-Perales C; Pérez-Guerrero A; Portolés A
Clin Investig Arterioscler; 2016; 28(5):209-215. PubMed ID: 27650658
[TBL] [Abstract][Full Text] [Related]
31. Influence of pre-existing inflammation on the outcome of acute coronary syndrome: a cross-sectional study.
Odeberg J; Freitag M; Forssell H; Vaara I; Persson ML; Odeberg H; Halling A; Råstam L; Lindblad U
BMJ Open; 2016 Jan; 6(1):e009968. PubMed ID: 26758266
[TBL] [Abstract][Full Text] [Related]
32. A multicentre, randomized, controlled open-label trial to compare an Accelerated Rule-Out protocol using combined prehospital copeptin and in-hospital high sensitive troponin with standard rule-out in patients suspected of acute Myocardial Infarction - the AROMI trial.
Pedersen CK; Stengaard C; Søndergaard H; Dodt KK; Hjort J; Bøtker MT; Terkelsen CJ
Trials; 2018 Dec; 19(1):683. PubMed ID: 30541594
[TBL] [Abstract][Full Text] [Related]
33. Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction study.
Arnetz L; Hage C; Brismar K; Catrina SB; Norhammar A; Lundman P; Wallander M; Ryden L; Mellbin L
Diab Vasc Dis Res; 2016 Jul; 13(4):307-11. PubMed ID: 27190088
[TBL] [Abstract][Full Text] [Related]
34. The diagnostic and prognostic value of first hour glycogen phosphorylase isoenzyme BB level in acute coronary syndrome.
Bozkurt S; Kaya EB; Okutucu S; Aytemir K; Coskun F; Oto A
Cardiol J; 2011; 18(5):496-502. PubMed ID: 21947984
[TBL] [Abstract][Full Text] [Related]
35. Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I.
Manginas A; Bei E; Chaidaroglou A; Degiannis D; Koniavitou K; Voudris V; Pavlides G; Panagiotakos D; Cokkinos DV
Clin Cardiol; 2005 Apr; 28(4):182-6. PubMed ID: 15869050
[TBL] [Abstract][Full Text] [Related]
36. [Usefulness of copeptin in discarding non-ST elevation acute myocardial infarction in patients with acute chest pain and negative first troponin I].
Esteban-Torrella P; García de Guadiana-Romualdo L; Consuegra-Sánchez L; Dau-Villarreal D; Melgarejo-Moreno A; Albaladejo-Otón MD; Villegas-García M
Med Intensiva; 2015 Nov; 39(8):477-82. PubMed ID: 25798956
[TBL] [Abstract][Full Text] [Related]
37. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
[TBL] [Abstract][Full Text] [Related]
38. Can copeptin and troponin T ratio predict final infarct size and myocardial salvage index in patients with ST-elevation myocardial infarction: A sub-study of the DANAMI-3 trial.
Árnadóttir Á; Schoos M; Lønborg J; Ahtarovski K; Kelbæk H; Helqvist S; Høfsten D; Clemmensen P; Engstrøm T; Nepper-Christensen L; Vejlstrup N; Køber L; Iversen K
Clin Biochem; 2018 Sep; 59():37-42. PubMed ID: 29932892
[TBL] [Abstract][Full Text] [Related]
39. The relation between oxidant and antioxidant parameters and severity of acute coronary syndromes.
Serdar Z; Serdar A; Altin A; Eryilmaz U; Albayrak S
Acta Cardiol; 2007 Aug; 62(4):373-80. PubMed ID: 17824298
[TBL] [Abstract][Full Text] [Related]
40. Acute coronary syndromes in the community.
Manemann SM; Gerber Y; Chamberlain AM; Dunlay SM; Bell MR; Jaffe AS; Weston SA; Killian JM; Kors J; Roger VL
Mayo Clin Proc; 2015 May; 90(5):597-605. PubMed ID: 25794453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
